Updated: Apr 13, 2022
*NIPT : Non-invasive prenatal test
G-NIPT is a Non-invasive prenatal test that uses NGS (Next Generation Sequencing) method to screen for major chromosomal aneuploidies
including Down Syndrome, Edward Syndrome and Patau Syndrome
from the fetal DNA present in the pregnant mother's blood.
More accurate than the existing blood test,
Faster and simpler than the amniocentesis tests.
GC Genome Offers 3 NIPT Options
In order to satisfy customers with various needs, we operate multiple NIPT options. GC Genome offers 3 versions of G-NIPT for providers and customers
to choose from based on their current needs.
Why you should select G-NIPT
1) Genome Wide Scanning: Screens all 23 pairs of chromosomes to detect not only chromosomal aneuploidies in T21, 18, 13 and sex chromosome, but also other chromosomal aneuploidies and deletion syndrome of certain sizes.
2)Double Screening for Sex chromosome aneuploidy: When there is sex chromosome aneuploidy detected in the NIPT, mother's DNA is analyzed again for confirmation, considering the possibility of maternal DNA interference.
3) Fetal Fraction Report: ACOG recommends NIPT providers to report the result only when the fetal fraction level (FF) is over 4%. G-NIPT result is only reported when FF is over 4%, and the exact fetal fraction number is specified on the report.
4) Twin Pregnancy Cases: Over 500 cases of twin pregnancy conducted. In case of more than one fetus, sex chromosome aneuploidy is not reported.
Download the required documents through the link below!
This test can be performed upon request from a medical doctor.
#Non-invasive prenatal test#G-NIPT#NIPT#NGS#Prenatal#Prenatal Chromosomal Abnormality Screening test